ASTROCYTES AFFECT NEUROPROTECTION: GLATIRAMER ACETATE IN HUNTINGTON'S DISEASE THERAPY

被引：0
|
作者：
Reick, C. [1 ,2 ]
Saft, C. [1 ]
Linker, R. A. [3 ]
Wiese, S. [2 ,4 ]
Gold, R. [1 ,2 ]
Ellrichmann, G. [1 ]
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
[2] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany
[3] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany
[4] Ruhr Univ Bochum, Grp Mol Cell Biol, Bochum, Germany
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2012年 / 83卷
关键词：
D O I：
10.1136/jnnp-2012-303524.169
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A54 / A54
页数：1
相关论文
共 50 条
  • [31] Glatiramer Acetate: A Novel Therapeutic Approach in Crohn's Disease?
    Neesse, Albrecht
    Michl, Patrick
    Kunsch, Steffen
    Gress, Thomas M.
    Steinkamp, Martin
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 156 - 157
  • [32] Interferon Beta and Glatiramer Acetate Therapy
    Corey A. McGraw
    Fred D. Lublin
    [J]. Neurotherapeutics, 2013, 10 : 2 - 18
  • [33] Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity
    Morigaki, Ryoma
    Goto, Satoshi
    [J]. BRAIN SCIENCES, 2017, 7 (06): : 02 - 25
  • [34] Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease
    Cardinale, Antonella
    Fusco, Francesca R.
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (04) : 319 - 328
  • [35] ACMSD Provides Neuroprotection in a Mouse Model of Huntington's Disease
    Fink, K. D.
    Deng, P.
    Cameron, D.
    Brundin, L.
    Manfredsson, F. P.
    [J]. CELL TRANSPLANTATION, 2021, 30 : 5 - 6
  • [36] Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington’s disease
    Zheng Wu
    Matthew Parry
    Xiao-Yi Hou
    Min-Hui Liu
    Hui Wang
    Rachel Cain
    Zi-Fei Pei
    Yu-Chen Chen
    Zi-Yuan Guo
    Sambangi Abhijeet
    Gong Chen
    [J]. Nature Communications, 11
  • [37] Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease
    Wu, Zheng
    Parry, Matthew
    Hou, Xiao-Yi
    Liu, Min-Hui
    Wang, Hui
    Cain, Rachel
    Pei, Zi-Fei
    Chen, Yu-Chen
    Guo, Zi-Yuan
    Abhijeet, Sambangi
    Chen, Gong
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [38] Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease
    Miyazaki, Ikuko
    Asanuma, Masato
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (33) : 4936 - 4947
  • [39] Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice
    Dedeoglu, A
    Kubilus, JK
    Yang, LC
    Ferrante, KL
    Hersch, SM
    Beal, MF
    Ferrante, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 (06) : 1359 - 1367
  • [40] Huntington's Disease: Astrocytes Shift to Fatty Acid Metabolism
    Van Houten, Bennett
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (09): : 575 - 577
12345